Grifols SA (GIFLF)
Grifols Market Cap : 7.568B for June 8, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pharma Mar SA | 1.848B |
| Oryzon Genomics SA | 286.80M |
| Agenus, Inc. | 120.00M |
| Amgen, Inc. | 185.99B |
| BioCryst Pharmaceuticals, Inc. | 2.115B |
Market Cap Related Metrics
| PE Ratio | 15.73 |
| PS Ratio | 0.8775 |
| PEG Ratio | 0.1211 |
| Price to Book Value | 1.203 |
| Price to Free Cash Flow | 10.81 |
| Price | 11.12 |
| Earnings Yield | 6.36% |
| PEGY Ratio | 0.1197 |
| Operating PE Ratio | 5.332 |
| Normalized PE Ratio | 16.43 |